Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.56 USD | -1.64% | -3.97% | -20.89% |
05-27 | Bristol Myers: will present data on schizophrenia | CF |
05-27 | Bristol Myers: presents over 130 studies at ASCO | CF |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.89% | 83.6B | |
+37.46% | 727B | |
-7.84% | 354B | |
+15.63% | 328B | |
-0.47% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+3.91% | 164B | |
-1.96% | 164B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- UBS Adjusts Bristol-Myers Squibb Price Target to $77 From $75, Maintains Neutral Rating